R. Michael Carruthers - 13 Jun 2024 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELEV	Stock Option (Right to Buy)	Award	$0	+35,000		$0.000000	35,000	13 Jun 2024	Common Stock	35,000	$3.35	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests as to 100% of the total shares on the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date.